Emergency nurse practitioner management of tetanus status and tetanus-prone wounds

References 

1. In:  Atkinson W,  Hamborsky J,  McIntyre L,  Wolfe E editor. Epidemiology and Prevention of Vaccine Preventable Diseases. 10th ed.. Washington, DC: Centre for Disease Control and Prevention, Public Health Foundation; 2007;
2. BNF, 2007. British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, London.
3. Brand D, Acampora D, Gottlieb L, Glancy K, Frazer W. Adequacy of antitetanus (sp) prophylaxis in six hospital emergency rooms. New England Journal of Medicine. 1983;309:636–640
4. Cook T, Protheroe R, Handel J. Tetanus: a review of the literature. British Journal of Anaesthesia. 2001;87(3):477–487
   • MEDLINE
   • CrossRef
5. Department of Health, 1990. Joint Committee on Vaccination and Immunisation: Tetanus Immunisation Against Infectious Disease. HMSO, London.
6. Department of Health, 2006. Immunisation Against Infectious Disease – ‘The Green Book’. Department of Health, TSO (Stationary Office).
7. Diggle L, Deeks J. Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial. British Medical Journal. 2000;321:931–933
8. Elkharrat D, Boyer C, Raskine L, Durand-Zaleske I, Zerbani A, Caulin C, et al. Impact of guidelines to alter antitetanus prophylaxis practices and reduce costs in emergency department. American Journal of Theatre. 1999;6:3–9
9. Elkharrat D, Debatisse A, Sanson-Le-Pors M, Le Corre A. Rapid test for assisting in unscheduled tetanus prophylaxis. Reunion Interdisciplianaire de Chimiotherapie Anti-Infectiuse, Paris. 2002;155:5–6
10. Espinoza P, Colombet I, Chatellier G, Sanson-Le Pors M, Coudert B, Sauguez C, et al. Multicenter study TETAQUICK 1000. European Congress of Emergency Medicine. 2005;
11. Fiorillo L, Robinson J. Localised tetanus in a child. Annals of Emergency Medicine. 1999;33:460–463
    • Abstract
    • Full Text
    • Full-Text PDF (47 KB)
    • CrossRef
12. Health Protection Agency, 2003. Cluster of cases of tetanus in injecting drug users. CDR Weekly, vol. 14, pp. 2–4.
13. Mark A, Carlsson R, Granstorm M. Subcutaneous versus intramuscular injection booster DT vaccination in adolescents. Vaccine. 1999;17:2067–2072
    • MEDLINE
    • CrossRef
14. Parini S. Vaccination do’s and don’ts. Nursing. 2003;33(12):58–64
15. Pascual F, McGinley E, Zanardi L. MMWR. 2003;52:1–8
16. Prodigy, 2006. Tetanus-prone wound. <http://www.prodigy.nhs.uk/patie.PDF> (accessed 20.03.07).
17. Prospect Diagnostics Limited, 2007. Protetanus Immunoassay Guidelines for Use. Prospect Diagnostics Ltd., Viking Court, 31 Princess Road, Dronfield, Derbyshire, S18 3LX.
18. Steimle D, Aston R, Van Damme P. Tetanus and diphtheria. Nursing Standard. 2002;16(22):33–35
19. Taian D, Abrahamian F, Moran G, Mower W, Alagappan K, Tiffany B. Tetanus immunity and physician compliance with tetanus prophylaxis among emergency department patients presenting with wounds. Annals Emergency Medicine. 2004;43:305–314
20. World Health Organisation, 2007. Tetanus. <http://www.who.int/immunization/topics/tetanus> (accessed 20.03.07).
21. Zuckerman J. The importance of injecting vaccines into muscle. British Medical Journal. 2000;321:1237–1238